Ever Source Wealth Advisors, LLC Biotechnology

Ever Source Wealth Advisors, LLC

$1.65 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
GLUE Monte Rosa Therapeutics, Inc.	$236M	$0 0.0% of portfolio	4	Q4 2024 New
ERAS Erasca, Inc.	$170M	$0 0.0% of portfolio	6	Q4 2024 New
IMRX Immuneering Corp	$38M	$0 0.0% of portfolio	345	Q2 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	71	Q4 2024 New
HUMA Humacyte, Inc.	$148M	$0 0.0% of portfolio	3	Q4 2024 New
TRDA Entrada Therapeutics, Inc.	$277M	$0 0.0% of portfolio	14	Q4 2024 New
TSVT 2seventy Bio, Inc.	$189M	$0 0.0% of portfolio	2	Q4 2024 New
LGVN Longeveron Inc.	$9.96M	$0 0.0% of portfolio	481	Q2 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$314M	$0 0.0% of portfolio	25	Q4 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$49.8M	$0 0.0% of portfolio	37	Q4 2024 New
GERN Geron Corp	$537M	$0 0.0% of portfolio	22	Q4 2024 New
MNKD Mannkind Corp	$1.22B	$0 0.0% of portfolio	108	Q4 2024 New
RGLS Regulus Therapeutics Inc.	$40.4M	$0 0.0% of portfolio	82	Q4 2024 New
ATOS Atossa Therapeutics, Inc.	$92.4M	$0 0.0% of portfolio	32	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$116M	$0 0.0% of portfolio	30	Q4 2024 New
PGEN Precigen, Inc.	$331M	$0 0.0% of portfolio	755	Q4 2024 New
MGNX Macrogenics Inc	$102M	$0 0.0% of portfolio	22	Q4 2024 New
CRMD Cor Medix Inc.	$375M	$0 0.0% of portfolio	4	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	7	Q4 2024 New
XNCR Xencor Inc	$627M	$0 0.0% of portfolio	2	Q4 2024 New
AKBA Akebia Therapeutics, Inc.	$436M	$0 0.0% of portfolio	14	Q4 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$33M	$0 0.0% of portfolio	74	Q4 2024 New
TBPH Theravance Biopharma, Inc.	$651M	$0 0.0% of portfolio	80	Q4 2024 New
SAGE Sage Therapeutics, Inc.	$463M	$0 0.0% of portfolio	1	Q4 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$132M	$0 0.0% of portfolio	32	Q4 2024 New
ALDX Aldeyra Therapeutics, Inc.	$156M	$0 0.0% of portfolio	15	Q4 2024 New
ATRA Atara Biotherapeutics, Inc.	$691M	$0 0.0% of portfolio	35	Q2 2024 New
FGEN Fibrogen Inc	$29.1M	$0 0.0% of portfolio	734	Q4 2023 New
RARE Ultragenyx Pharmaceutical Inc.	$2.67B	$0 0.0% of portfolio	13	Q4 2024 New
CLLS Cellectis S.A.	$67.4M	$0 0.0% of portfolio	13	Q1 2023 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	5	Q4 2024 New
MCRB Seres Therapeutics, Inc.	$1.25B	$0 0.0% of portfolio	666	Q2 2024 New
RGNX Regenxbio Inc.	$396M	$0 0.0% of portfolio	12	Q4 2024 New
ARVN Arvinas, Inc.	$482M	$0 0.0% of portfolio	13	Q4 2024 Added 8.33%
BCYC Bicycle Therapeutics PLC	$250M	$0 0.0% of portfolio	24	Q4 2024 Added 20.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.